Clinical Research Directory

Inclusion Criteria: * Age ≥ 18 years old * Signed written informed consent * French Social Security affiliation * For child-bearing aged women, effective form of contraception\* * Diagnosis of primary aldosteronism: * With or without adrenal nodule on morphological imaging (CT or Magnetic Resonance Imaging) * With unilateral or bilateral aldosterone secretion confirmed by invasive AVS * Such methods include: combined hormonal contraception, progestogen-only hormonal contraception, intrauterine device (IUD) or hormone-releasing system (IUS), bilateral tubal occlusion, vasectomised partner, condom, sexual abstinence. Exclusion Criteria: * Pregnant or breastfeeding women * Patient under legal protection (guardianship) * Contraindication to the PET-CT * Contraindication to the injection of \[68Ga\]Ga-PentixaFor * Participation in another interventional study involving human participants or being in the exclusion period at the end of a previous study involving human participants, if applicable * Patient on AME (state medical aid) (unless exemption from affiliation) * Completed group: if the expected number of patients has been reached (15 patients) in the corresponding group of patients (with lateralized or non-lateralized PA).